Nanomedicine News RSS Feed - Nanomedicine

Nanopropellers for Microscopic Medicine

Nanopropellers for Microscopic Medicine

If you thought that the most impressive news in shrinking technology these days was smart watches, think again. Scientists are quietly toiling in their laboratories to create robots that are only nanometers – billionths of a meter – in length, small enough to maneuver inside the human body and possibly inside human cells. [More]
Imbed Bio Awarded NIH SBIR Phase II Grant to Develop Polymeric Nanofilm Dressings with Silver Nanoparticles

Imbed Bio Awarded NIH SBIR Phase II Grant to Develop Polymeric Nanofilm Dressings with Silver Nanoparticles

Imbed Biosciences, Inc, a medical device company developing advanced materials for wound healing and surgical applications, announced today that it has been awarded a $1.5M competitive Small Business Innovation Research (SBIR) Phase II grant from National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a division of National Institutes of Health (NIH). [More]
Peer-Reviewed Nanomaterials and Nanotechnology Journal Receives 0.949 Impact Factor

Peer-Reviewed Nanomaterials and Nanotechnology Journal Receives 0.949 Impact Factor

Nanomaterials and Nanotechnology journal has received its first Journal Impact Factor of 0.949 as of July 29th, 2014. Up to this date, all journal's Volumes have been indexed in SCIE and Current Contents databases, as well as in Scopus. [More]
Nanoparticles Jumpstart Body's Ability to Fight Tumors

Nanoparticles Jumpstart Body's Ability to Fight Tumors

Researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center are exploring ways to wake up the immune system so it recognizes and attacks invading cancer cells. Tumors protect themselves by tricking the immune system into accepting everything as normal, even while cancer cells are dividing and spreading. [More]
SapC-DOPS May be Used for Treatment of Brain Cancer

SapC-DOPS May be Used for Treatment of Brain Cancer

Over half of patients being seen in the clinic for a diagnosed brain tumor have metastatic cancer, which has no treatment and detrimental outcomes in most cases. [More]
NanoViricides Dedicates New R&D and cGMP Pilot Manufacturing Facility

NanoViricides Dedicates New R&D and cGMP Pilot Manufacturing Facility

NanoViricides, Inc. celebrated the grand opening of its new R&D and cGMP pilot manufacturing facility with Congressman Jim Himes as the Chief Guest yesterday, July 21. [More]
DNA-Wrapped Carbon Nanotube Can Detect Cancers Before Metastasization

DNA-Wrapped Carbon Nanotube Can Detect Cancers Before Metastasization

Since they were first developed a quarter-century ago, carbon nanotubes (CNTs) have impressed scientists with their mechanical strength and stiffness, their optical performance, and their ability to conduct heat and electricity. [More]
New Material Holds Potential for Development of New Formulations of Rejected Drugs

New Material Holds Potential for Development of New Formulations of Rejected Drugs

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. [More]
Novel Nano-Sized Vaccine Package Can Combat Dust-Mite Allergies

Novel Nano-Sized Vaccine Package Can Combat Dust-Mite Allergies

If you’re allergic to dust mites (and chances are you are), help may be on the way. [More]
Tekmira Preparing Complete Response to FDA for TKM-Ebola Phase I Clinical Hold

Tekmira Preparing Complete Response to FDA for TKM-Ebola Phase I Clinical Hold

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today announced an update on the TKM-Ebola Phase I clinical hold. The Company has received the clinical hold letter from the U.S. Food and Drug Administration (FDA) and is preparing a Complete Response to the Agency. The Company anticipates this matter will be resolved by Q4, 2014. [More]